GAP JUNCTIONS & ION CHANNELS IN CORPUS CAVERNOSUM
缝隙连接
基本信息
- 批准号:2430204
- 负责人:
- 金额:$ 22.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-06-01 至 1999-05-31
- 项目状态:已结题
- 来源:
- 关键词:action potentials calcium channel electrophysiology fluorescent dye /probe gap junctions gene expression human subject immunoelectron microscopy immunofluorescence technique impotence membrane channels messenger RNA muscle cells muscle contraction muscle relaxation muscle tone northern blottings penis disorder penis erection potassium channel second messengers smooth muscle tissue /cell culture voltage /patch clamp western blottings
项目摘要
Erectile dysfunction is a major health problem that has a dramatic impact
on the quality of life of many men and their sexual partners. Moreover,
erectile dysfunction represents a spectrum of disease, ranging from
partial to complete impotence, and affecting an estimated 18-30 million
American men greater than or equal to 40 years of age. Medical treatment
of this prevalent disease resulted in 400,000 outpatient visits and 30,000
hospital admissions, at total cost of $146 million in 1985 alone.
Incomplete corporal smooth muscle relaxation is now widely recognized as
a significant etiologic factor in a large proportion of impotent men. The
general consensus is that incomplete corporal smooth muscle relaxation
severely compromises trapping of blood in the corporal sinuses (because of
incomplete closure of the venous outflow), resulting in a lack of
rigidity. This condition is commonly referred to as corporal veno-
occlusive erectile dysfunction. In vitro studies have documented that
isolated human corporal tissue strips and cultured corporal smooth muscle
cells provide a valid model for studying at least some aspects of the
modulation of corporal smooth muscle tone in vivo. Observations both in
vitro and in vivo demonstrated that intercellular communication through
gap junctions, and current flow through membrane ion channels (i.e.,
namely Ca & K channels) are important modulators of corporal smooth muscle
tone, and therefore, of erectile capacity. It seems that regardless of the
diversity of causes of erectile dysfunction related to incomplete corporal
smooth muscle relaxation, their effects might still be explained via their
direct or indirect impact on gap junctions, K channels or Ca channels.
Thus, in many ways, the improved understanding, diagnosis and treatment of
erectile dysfunction is largely dependent on more detailed knowledge of
how physiologically relevant drugs modulate these primary effectors of
corporal smooth muscle tone. To directly address this issue we shall: l:
a) Conduct electrophysiological studies on enzymatically dispersed and
cultured corporal smooth muscle cells to evaluate the role of
intercellular current flow in propagating and amplifying signals in the
corpora. b) Microinject cultured and enzymatically dissociated cells as
well as isolated tissue strips with gap junction permeant dyes and second
messenger molecules to assess the role of metabolic coupling in
propagating and amplifying signals in the corpora. c) Conduct molecular
biological and immunocytochemical studies to characterize gap junctions
between smooth muscle cells in situ and in culture. 2) Use patch clamp
techniques to characterize the K and Ca channels in enzymatically
dispersed and cultured corporal smooth muscle cells. 3) Assess action
potential generation in vitro, using the sucrose gap technique.
勃起功能障碍是一个主要的健康问题,有戏剧性的影响,
对许多男性及其性伴侣的生活质量的影响。此外,委员会认为,
勃起功能障碍代表了一系列疾病,
部分至完全阳痿,估计影响1800万至3000万人,
美国男性大于或等于40岁。医疗
这一流行病的发病率导致40万门诊病人和3万
住院费用,单是一九八五年一年,就达一亿四千六百万元。
不完全的身体平滑肌松弛现在被广泛认为是
一个重要的病因在很大比例的男性阳痿。的
普遍的共识是,不完全的身体平滑肌松弛
严重损害了身体鼻窦中的血液滞留(因为
静脉流出的不完全闭合),导致缺乏
刚度这种情况通常被称为身体静脉-
闭塞性勃起功能障碍体外研究已经证明,
分离的人身体组织条和培养的身体平滑肌
细胞提供了有效的模型,用于研究细胞的至少一些方面。
调节体内的体平滑肌张力。观察结果,
体外和体内研究表明,细胞间通讯通过
间隙连接和流过膜离子通道的电流(即,
即Ca和K通道)是体平滑肌的重要调节剂
因此,勃起能力。看来,不管
勃起功能障碍的原因有哪些?
平滑肌松弛,它们的作用仍然可以通过它们的
直接或间接影响缝隙连接、K通道或Ca通道。
因此,在许多方面,提高对疾病的理解、诊断和治疗,
勃起功能障碍在很大程度上依赖于更详细的知识,
生理相关药物如何调节这些主要效应物,
体平滑肌张力为了直接解决这个问题,我们应该:l:
a)对酶促分散的和
培养的海绵体平滑肌细胞,以评估
在细胞内传播和放大信号的细胞间电流
语料库B)显微注射培养的和酶促解离的细胞,
以及具有间隙连接渗透染料的分离的组织条,
信使分子,以评估代谢偶联在
在语料库中传播和放大信号。c)传导分子
生物学和免疫细胞化学研究来表征缝隙连接
平滑肌细胞在原位和培养中的差异。2)使用膜片钳
技术来表征钾和钙通道在酶
分离培养的海绵体平滑肌细胞。3)评估行动
在体外的潜力代,使用蔗糖间隙技术。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
George Joseph Christ其他文献
George Joseph Christ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('George Joseph Christ', 18)}}的其他基金
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8447148 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8549233 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8720940 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8720939 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8566193 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Regeneration, Repair and Remodeling of the Lower Urinary Tract
下尿路的再生、修复和重塑
- 批准号:
8642277 - 财政年份:2012
- 资助金额:
$ 22.88万 - 项目类别:
Novel Studies of Bladder Regeneration in a Rodent Model
啮齿动物模型膀胱再生的新研究
- 批准号:
7903769 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:
Development of Bioengineered Skeletal Muscle for Functional Replacement in vivo
开发用于体内功能替代的生物工程骨骼肌
- 批准号:
7924048 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:
Development of Bioengineered Skeletal Muscle for Functional Replacement in vivo
开发用于体内功能替代的生物工程骨骼肌
- 批准号:
7626520 - 财政年份:2009
- 资助金额:
$ 22.88万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 22.88万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 22.88万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 22.88万 - 项目类别:














{{item.name}}会员




